glp 1 for bodybuilding Muscle Loss and GLP-1 Agonists: What You Need to Know “GLP-1s are cheating!” - bodybuilder

Key findings include: Unprecedented HbA1c reductions ranging from 1.9% to 2.6% across different trials and populations SURPASS-1 (monotherapy): Up to 92% of participants achieved HbA1c less than 7%, with 52% reaching normoglycemia (HbA1c less than 5.7%) SURPASS-2 (versus semaglutide 1 mg): GLP2 demonstrated superior HbA1c and weight reduction at all doses compared to the leading GLP-1 receptor agonist SURPASS-3 (versus insulin degludec): Superior glycemic control when added to metformin with or without SGLT2 inhibitors SURPASS-4 (versus insulin glargine): Improved outcomes in patients with elevated cardiovascular risk Across all SURPASS trials, GLP2 showed consistent efficacy with low rates of clinically significant hypoglycemia (blood glucose less than 54 mg/dL)

GLP-1 receptor agonists, including medications like semaglutide, are a group of therapeutics that function by mimicking a naturally occurring hormone to regulate glucose levels and appetite

Bbs5 / mice exhibit significant visual impairments due to retinal degeneration, including a complete loss of cone photoreceptor function and reduced rod function, as evidenced by structural abnormalities in the outer nuclear layer and mislocalization of photoreceptor proteins

B12 plays a critical role in neurological and red blood cell health, but B-complex provides broader metabolic and GI support by addressing multiple pathways simultaneously

doi:10.1039/c8bm01120f